Study Evaluating CMD-193 in Advanced Malignant Solid Tumors
Clinical trial NCT00161642 · COMPLETED
Trial details
- NCT number
- NCT00161642
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
- Primary completion
- 2007-07-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.